<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK83297" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK83297/" /><meta name="ncbi_pagename" content="Salih Myopathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Salih Myopathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Salih Myopathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/04/11" /><meta name="citation_author" content="Peter Hackman" /><meta name="citation_author" content="Marco Savarese" /><meta name="citation_author" content="Virginie Carmignac" /><meta name="citation_author" content="Bjarne Udd" /><meta name="citation_author" content="Mustafa A Salih" /><meta name="citation_pmid" content="22238790" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK83297/" /><meta name="citation_keywords" content="Early-Onset Myopathy with Fatal Cardiomyopathy" /><meta name="citation_keywords" content="Early-Onset Myopathy with Fatal Cardiomyopathy" /><meta name="citation_keywords" content="Titin" /><meta name="citation_keywords" content="TTN" /><meta name="citation_keywords" content="Salih Myopathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Salih Myopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Peter Hackman" /><meta name="DC.Contributor" content="Marco Savarese" /><meta name="DC.Contributor" content="Virginie Carmignac" /><meta name="DC.Contributor" content="Bjarne Udd" /><meta name="DC.Contributor" content="Mustafa A Salih" /><meta name="DC.Date" content="2019/04/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK83297/" /><meta name="description" content="Salih myopathy is characterized by muscle weakness (manifest during the neonatal period or in early infancy) and delayed motor development; children acquire independent walking between ages 20 months and four years. In the first decade of life, global motor performance is stable or tends to improve. Moderate joint and neck contractures and spinal rigidity may manifest in the first decade but become more obvious in the second decade. Scoliosis develops after age 11 years. Cardiac dysfunction manifests between ages five and 16 years, progresses rapidly, and leads to death between ages eight and 20 years, usually from heart rhythm disturbances." /><meta name="og:title" content="Salih Myopathy" /><meta name="og:type" content="book" /><meta name="og:description" content="Salih myopathy is characterized by muscle weakness (manifest during the neonatal period or in early infancy) and delayed motor development; children acquire independent walking between ages 20 months and four years. In the first decade of life, global motor performance is stable or tends to improve. Moderate joint and neck contractures and spinal rigidity may manifest in the first decade but become more obvious in the second decade. Scoliosis develops after age 11 years. Cardiac dysfunction manifests between ages five and 16 years, progresses rapidly, and leads to death between ages eight and 20 years, usually from heart rhythm disturbances." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK83297/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/salih-myo/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK83297/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D2D72E040E7210000000004230196.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK83297_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK83297_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/scs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/siod/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK83297_"><span class="title" itemprop="name">Salih Myopathy</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Early-Onset Myopathy with Fatal Cardiomyopathy</div><p class="contrib-group"><span itemprop="author">Peter Hackman</span>, PhD, <span itemprop="author">Marco Savarese</span>, PhD, <span itemprop="author">Virginie Carmignac</span>, PhD, <span itemprop="author">Bjarne Udd</span>, MD, PhD, and <span itemprop="author">Mustafa A Salih</span>, MB BS, MPCH, MD, Dr Med Sci, FRCPCH, FAAN.</p><a data-jig="ncbitoggler" href="#__NBK83297_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK83297_ai__"><div class="contrib half_rhythm"><span itemprop="author">Peter Hackman</span>, PhD<div class="affiliation small">The Folkh&#x000e4;lsan Institute of Genetics and the Department of Medical Genetics<br />Haartman Institute<br />University of Helsinki<br />Helsinki, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.iknisleh@namkcah.retep" class="oemail">if.iknisleh@namkcah.retep</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Marco Savarese</span>, PhD<div class="affiliation small">The Folkh&#x000e4;lsan Institute of Genetics and the Department of Medical Genetics<br />Haartman Institute<br />University of Helsinki<br />Helsinki, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.iknisleh@eseravas.ocram" class="oemail">if.iknisleh@eseravas.ocram</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Virginie Carmignac</span>, PhD<div class="affiliation small">Equipe G&#x000e9;n&#x000e9;tique des Anomalies du D&#x000e9;veloppement<br />IFR Sant&#x000e9;-STIC<br />Universit&#x000e9; de Bourgogne<br />Dijon, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@cangimrac.einigriv" class="oemail">moc.liamg@cangimrac.einigriv</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bjarne Udd</span>, MD, PhD<div class="affiliation small">Tampere Neuromuscular Research Unit<br />The Folkh&#x000e4;lsan Institute of Genetics and the Department of Medical Genetics<br />Haartman Institute<br />University of Helsinki<br />Helsinki, Finland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="if.phsp@ddu.enrajb" class="oemail">if.phsp@ddu.enrajb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Mustafa A Salih</span>, MB BS, MPCH, MD, Dr Med Sci, FRCPCH, FAAN<div class="affiliation small">Division of Pediatric Neurology<br />College of Medicine<br />King Saud University<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@50hilas_afatsum" class="oemail">moc.oohay@50hilas_afatsum</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 12, 2012</span>; Last Update: <span itemprop="dateModified">April 11, 2019</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="salih-myo.Summary" itemprop="description"><h2 id="_salih-myo_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Salih myopathy is characterized by muscle weakness (manifest during the neonatal period or in early infancy) and delayed motor development; children acquire independent walking between ages 20 months and four years. In the first decade of life, global motor performance is stable or tends to improve. Moderate joint and neck contractures and spinal rigidity may manifest in the first decade but become more obvious in the second decade. Scoliosis develops after age 11 years. Cardiac dysfunction manifests between ages five and 16 years, progresses rapidly, and leads to death between ages eight and 20 years, usually from heart rhythm disturbances.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in the first three M-line-encoding exons (Mex1, Mex2, and Mex3) of <i>TTN</i>, the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause Salih myopathy.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Care, best provided by a multidisciplinary team, includes stretching exercises and physical therapy; assistive mechanical devices for sitting and ambulation as needed; and appropriate technical support in educational settings. Treat heart failure and cardiac arrhythmia as soon as they are evident. Cardiac transplantation may be considered for progressive dilated cardiomyopathy and heart failure refractory to medical therapy.</p><p><i>Prevention of secondary complications:</i> Annual influenza vaccine and other respiratory infection-related immunizations are advised. Aggressive treatment of lower-respiratory tract infections.</p><p><i>Surveillance:</i> Electrocardiogram (ECG), 24-hour Holter ECG, and echocardiogram every six months beginning at age five years. Annual evaluation of respiratory function beginning at age 10 years. Clinical examination and x-ray as needed for orthopedic complications (e.g., foot deformity, joint contractures, spinal deformity).</p><p><i>Agents/circumstances to avoid:</i> Ibuprofen in those with congestive heart failure.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Salih myopathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>) and are asymptomatic. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified.</p></div></div><div id="salih-myo.Diagnosis"><h2 id="_salih-myo_Diagnosis_">Diagnosis</h2><div id="salih-myo.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Salih myopathy <b>should be suspected</b> in individuals with the following clinical, laboratory, electrophysiologic, imaging, and histopathology findings.</p><p><b>Clinical</b></p><ul><li class="half_rhythm"><div>Muscle weakness manifesting during the neonatal period or in early infancy</div></li><li class="half_rhythm"><div>Delayed motor milestones but normal cognitive development</div></li><li class="half_rhythm"><div>Muscle weakness of limb-girdle distribution, myopathic face, variable degree of ptosis, and relative calf muscle hypertrophy</div></li><li class="half_rhythm"><div>Development of dilated cardiomyopathy between ages five and 16 years</div></li><li class="half_rhythm"><div>Major heart rhythm disturbances leading to sudden death before age 20 years</div></li></ul><p><b>Laboratory.</b> Serum creatine kinase (CK) is marginally to moderately increased (1.5-7x normal).</p><p><b>Electrophysiologic</b></p><ul><li class="half_rhythm"><div><b>Electrocardiography.</b> Left axis deviation (left anterior fascicular block) can be seen as early as age four years (<a class="figpopup" href="/books/NBK83297/figure/salih-myo.F1/?report=objectonly" target="object" rid-figpopup="figsalihmyoF1" rid-ob="figobsalihmyoF1">Figure 1</a>). With the onset of dilated cardiomyopathy, rhythm disturbances can include polymorphic premature ventricular complexes, bigeminism and trigeminism, couplets, triplets, atrioventricular heart block, atrioventricular nodal reentrant tachycardia, premature atrial complexes, premature ventricular complexes, and ventricular tachycardia.</div></li><li class="half_rhythm"><div><b>Electromyography</b> shows myopathic features (low-amplitude polyphasic potentials of short duration).</div></li><li class="half_rhythm"><div><b>Nerve conduction studies</b> are normal.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figsalihmyoF1" co-legend-rid="figlgndsalihmyoF1"><a href="/books/NBK83297/figure/salih-myo.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figsalihmyoF1" rid-ob="figobsalihmyoF1"><img class="small-thumb" src="/books/NBK83297/bin/salih-myo-Image001.gif" src-large="/books/NBK83297/bin/salih-myo-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndsalihmyoF1"><h4 id="salih-myo.F1"><a href="/books/NBK83297/figure/salih-myo.F1/?report=objectonly" target="object" rid-ob="figobsalihmyoF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Electrocardiogram at age four years showing left axis deviation (left anterior fascicular block) </p></div></div><p><b>Echocardiogram</b> reveals, at the onset of cardiomyopathy, reduced function of the left ventricle and dilatation and global hypokinesia without wall hypertrophy. Later, dilatation involves the left atrium and ventricle, subsequently affecting all chambers.</p><p><b>Skeletal muscle biopsy.</b> The following findings help distinguish Salih myopathy from <a href="/books/n/gene/cmd-overview/">congenital muscular dystrophy</a> (CMD) and other <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathies. Muscle biopsy sections should be examined for histology, histochemistry, immunohistochemistry, and electron microscopy:</p><ul><li class="half_rhythm"><div class="half_rhythm">Histology of skeletal muscle reveals a pattern compatible with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> myopathy (<a class="figpopup" href="/books/NBK83297/figure/salih-myo.F2/?report=objectonly" target="object" rid-figpopup="figsalihmyoF2" rid-ob="figobsalihmyoF2">Figure 2</a>): mild variation in fiber size, abundant centrally located nuclei, no increase in connective tissue before age six years, and mild endomysial fibrosis after age six years.</div><div class="half_rhythm">Oxidative stains reveal multiple small lesions of reduced or absent oxidative activity with poorly defined boundaries.</div><div class="half_rhythm">Myofibrillar ATpase staining shows remarkable type 1 fiber predominance (&#x0003e;90%). In one individual, massive muscle fiber loss was seen in a second biopsy taken at age ten years [<a class="bk_pop" href="#salih-myo.REF.carmignac.2007.340">Carmignac et al 2007</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Immunohistochemistry</b> of skeletal muscle shows normal expression of dystrophin, laminin &#x003b1;2 chain (merosin), integrin &#x003b1;7, &#x003b1;- and &#x003b2;-dystroglycan, desmin, emerin, and the sarcoglycans &#x003b1; (adhalin), &#x003b2;, &#x003b3;, and &#x003b4;.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Electron microscopy</b> of skeletal muscle (<a class="figpopup" href="/books/NBK83297/figure/salih-myo.F3/?report=objectonly" target="object" rid-figpopup="figsalihmyoF3" rid-ob="figobsalihmyoF3">Figure 3</a>) highlights the "minicore-like" lesions seen on histology and reveals multiple foci of sarcomere disruption and mitochondria depletion.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figsalihmyoF2" co-legend-rid="figlgndsalihmyoF2"><a href="/books/NBK83297/figure/salih-myo.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figsalihmyoF2" rid-ob="figobsalihmyoF2"><img class="small-thumb" src="/books/NBK83297/bin/salih-myo-Image002.gif" src-large="/books/NBK83297/bin/salih-myo-Image002.jpg" alt="Figure 2. . Skeletal muscle histology of two children with Salih myopathy taken at age four years (A and D) and 14 years (B and C)." /></a><div class="icnblk_cntnt" id="figlgndsalihmyoF2"><h4 id="salih-myo.F2"><a href="/books/NBK83297/figure/salih-myo.F2/?report=objectonly" target="object" rid-ob="figobsalihmyoF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Skeletal muscle histology of two children with Salih myopathy taken at age four years (A and D) and 14 years (B and C). A and D. The early biopsy shows (A) increased fiber size variability, abundant centrally located nuclei (CNLs) but no endomyseal fibrosis <a href="/books/NBK83297/figure/salih-myo.F2/?report=objectonly" target="object" rid-ob="figobsalihmyoF2">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figsalihmyoF3" co-legend-rid="figlgndsalihmyoF3"><a href="/books/NBK83297/figure/salih-myo.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figsalihmyoF3" rid-ob="figobsalihmyoF3"><img class="small-thumb" src="/books/NBK83297/bin/salih-myo-Image003.gif" src-large="/books/NBK83297/bin/salih-myo-Image003.jpg" alt="Figure 3. . Longitudinal electron microscopy section of skeletal muscle taken at age ten years reveals focal disruptions of sarcomeric structures (arrows), Z-disk abnormalities including focal loss of dark Z-disk material, and early dissolution of I-band filaments (original magnification x6000)." /></a><div class="icnblk_cntnt" id="figlgndsalihmyoF3"><h4 id="salih-myo.F3"><a href="/books/NBK83297/figure/salih-myo.F3/?report=objectonly" target="object" rid-ob="figobsalihmyoF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Longitudinal electron microscopy section of skeletal muscle taken at age ten years reveals focal disruptions of sarcomeric structures (arrows), Z-disk abnormalities including focal loss of dark Z-disk material, and early dissolution of I-band filaments <a href="/books/NBK83297/figure/salih-myo.F3/?report=objectonly" target="object" rid-ob="figobsalihmyoF3">(more...)</a></p></div></div></div><div id="salih-myo.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Salih myopathy <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in M-line-encoding exons Mex1, Mex2, and Mex3* of <i>TTN</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK83297/table/salih-myo.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figsalihmyoTmoleculargenetictestingus" rid-ob="figobsalihmyoTmoleculargenetictestingus">Table 1</a>).</p><p>*Note: The last six exons of <i>TTN</i> (359 to 364 in the LRG [<a href="https://www.ncbi.nlm.nih.gov/nuccore/NG_011618.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NG_011618.3</a>] numbering that numbers the exons sequentially along the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a>; C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>) encode the part of titin that spans the sarcomere M-line; these exons are called Mex1-Mex6 for "M-line-encoding exons 1 through 6." For mapping of these exons to other transcripts, see <a href="#salih-myo.Molecular_Genetics">Molecular Genetics</a>.</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Salih myopathy is broad, individuals with the distinctive findings described in <a href="#salih-myo.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#salih-myo.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with myopathy and/or cardiomyopathy are more likely to be diagnosed using genomic testing (see <a href="#salih-myo.Option_2">Option 2</a>).</p><div id="salih-myo.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of Salih myopathy, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>TTN</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of select exons (Mex1, Mex2, Mex3) first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <i>TTN</i> sequence analysis of the remaining exons and <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</div><div class="half_rhythm">Note: If <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>TTN</i> pathogenic variants are not identified with the above testing, RNA sequencing to identify variants that alter <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> and/or expression and western blot analysis can be considered; however, such testing may not be available on a clinical basis [<a class="bk_pop" href="#salih-myo.REF.savarese.2018a.11">Savarese et al 2018a</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TTN</i> and other genes of interest (see <a href="#salih-myo.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of Salih myopathy, some panels for myopathy and/or cardiomyopathy may not include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="salih-myo.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by myopathy, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="salih-myo.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Salih Myopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK83297/table/salih-myo.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__salih-myo.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTN</i></td><td headers="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_salih-myo.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown, none reported</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="salih-myo.TF.1.1"><p class="no_margin">See <a href="/books/NBK83297/#salih-myo.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="salih-myo.TF.1.2"><p class="no_margin">See <a href="#salih-myo.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="salih-myo.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="salih-myo.TF.1.4"><p class="no_margin">To date, <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants reported to cause Salih myopathy are small frameshifts in M-line-encoding exons of <i>TTN</i> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001256850.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001256850<wbr style="display:inline-block"></wbr>​.1</a>:exons 358-360, termed Mex1 - Mex3) in <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families of Moroccan and Sudanese origin [<a class="bk_pop" href="#salih-myo.REF.carmignac.2007.340">Carmignac et al 2007</a>] (see <a href="#salih-myo.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>5. </dt><dd><div id="salih-myo.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="salih-myo.Clinical_Characteristics"><h2 id="_salih-myo_Clinical_Characteristics_">Clinical Characteristics</h2><div id="salih-myo.Clinical_Description"><h3>Clinical Description</h3><p>Salih myopathy is characterized by muscle weakness manifest during the neonatal period or in early infancy, and delayed motor development. Children acquire independent walking between ages 20 months and four years. In the first decade of life, global motor performance is stable or tends to improve. During this period skeletal muscle involvement mainly manifests as difficulty in running, climbing stairs, and rising from a sitting position. Those who survive childhood remain ambulant, with or without support, and maintain normal cognitive function.</p><p><b>Musculoskeletal.</b> Moderate joint and neck contractures and spinal rigidity may appear in the first decade but become more obvious in the second decade. Respiratory function tests show a moderate restrictive pattern. Scoliosis develops after age 11 years.</p><p><b>Cardiac dysfunction</b> manifests between ages five and 16 years and progresses rapidly, leading to death between ages eight and 20 years. Heart rhythm disturbances are the major cause of sudden death and their frequency and severity suggest primary involvement of the conduction system.</p><p><b>Electrocardiography (ECG)</b> is very helpful in signaling the occurrence of cardiac involvement. Left axis deviation (left anterior fascicular block) can be seen as early as age four years (<a class="figpopup" href="/books/NBK83297/figure/salih-myo.F1/?report=objectonly" target="object" rid-figpopup="figsalihmyoF1" rid-ob="figobsalihmyoF1">Figure 1</a>). With the onset of dilated cardiomyopathy (between ages 5 and 16 years), major rhythm disturbances become evident on ECG and Holter monitoring, including polymorphic premature ventricular complexes, bigeminism and trigeminism, couplets, triplets, atrioventricular heart block, atrioventricular nodal reentrant tachycardia, premature atrial complexes, premature ventricular complexes, and ventricular tachycardia.</p><p><b>Echocardiogram</b> reveals, at the onset of cardiomyopathy, reduced function of the left ventricle and dilatation and global hypokinesia without wall hypertrophy. Later, dilatation involves the left atrium and ventricle, subsequently affecting all chambers and leading to congestive heart failure.</p><p><b>Radionuclide angiography</b> using MUGA (<i>mu</i>lti-<i>g</i>ated <i>a</i>cquisition) scan reveals the deteriorating ventricular function with reduction of the left ventricular ejection fraction followed by reduction of the right ventricle ejection fraction.</p><p><b>Heart muscle biopsies</b> (taken from 2 individuals) showed increased interstitial fibrosis compatible with dilated cardiomyopathy [<a class="bk_pop" href="#salih-myo.REF.carmignac.2007.340">Carmignac et al 2007</a>]. Oxidative staining was normal without focal oxidative defects or significant disarray of the cardiomyocyte structure, in contrast to the classic observation in hypertrophic cardiomyopathy.</p><p><b>Heterozygotes.</b> In contrast to individuals with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>TTN</i> associated with <a href="/books/n/gene/udd/">Udd distal myopathy</a>, the heterozygous parents of individuals with Salih myopathy remain asymptomatic with no cardiac or muscle disorder (<a class="figpopup" href="/books/NBK83297/figure/salih-myo.F4/?report=objectonly" target="object" rid-figpopup="figsalihmyoF4" rid-ob="figobsalihmyoF4">Figure 4</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figsalihmyoF4" co-legend-rid="figlgndsalihmyoF4"><a href="/books/NBK83297/figure/salih-myo.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figsalihmyoF4" rid-ob="figobsalihmyoF4"><img class="small-thumb" src="/books/NBK83297/bin/salih-myo-Image004.gif" src-large="/books/NBK83297/bin/salih-myo-Image004.jpg" alt="Figure 4. . Mid-calf muscle MRI of parents of a proband at age (A) 55 years and (B) 44 years were normal and showed no fatty degeneration of the anterior tibial muscles." /></a><div class="icnblk_cntnt" id="figlgndsalihmyoF4"><h4 id="salih-myo.F4"><a href="/books/NBK83297/figure/salih-myo.F4/?report=objectonly" target="object" rid-ob="figobsalihmyoF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Mid-calf muscle MRI of parents of a proband at age (A) 55 years and (B) 44 years were normal and showed no fatty degeneration of the anterior tibial muscles. </p></div></div></div><div id="salih-myo.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are known.</p></div><div id="salih-myo.Nomenclature"><h3>Nomenclature</h3><p>Salih myopathy was initially referred to as Salih <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy [<a class="bk_pop" href="#salih-myo.REF.salih.1998.289">Salih et al 1998</a>, <a class="bk_pop" href="#salih-myo.REF.subahi.2001.297">Subahi 2001</a>]. Subsequently, it was renamed Salih myopathy [<a class="bk_pop" href="#salih-myo.REF.fukuzawa.2008.1841">Fukuzawa et al 2008</a>, <a class="bk_pop" href="#salih-myo.REF.pernigo.2010.2908">Pernigo et al 2010</a>].</p></div><div id="salih-myo.Prevalence"><h3>Prevalence</h3><p>Salih myopathy is thought to be rare. It has been described in <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families of Arab descent originating from Sudan and Morocco. The actual prevalence is unknown.</p></div></div><div id="salih-myo.Genetically_Related_Allelic_Di"><h2 id="_salih-myo_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p><b>Limb-girdle muscular dystrophy type 2J</b> (LGMD2J), which is allelic to Salih myopathy and is caused by mutation of the C terminus of <i>TTN</i>, has a later onset (childhood or later) than Salih myopathy.</p><p>Other phenotypes known to be associated with <i>TTN</i> include the following <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> disorders:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/hyper-card/">Hypertrophic cardiomyopathy</a> (HCM)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/dcm-ov/">Dilated cardiomyopathy</a> (DCM)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/udd/">Udd distal myopathy</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/hmerf/">Hereditary myopathy with early respiratory failure</a> (HMERF)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/arvd/">Arrhythmogenic right ventricular cardiomyopathy</a></div></li></ul><p>For comprehensive reviews of <i>TTN</i>-related disorders, see <a class="bk_pop" href="#salih-myo.REF.savarese.2016.293">Savarese et al [2016]</a> and <a class="bk_pop" href="#salih-myo.REF.hackman.2017.396">Hackman et al [2017]</a>.</p></div><div id="salih-myo.Differential_Diagnosis"><h2 id="_salih-myo_Differential_Diagnosis_">Differential Diagnosis</h2><div id="salih-myo.T.earlyonset_muscle_disorders" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Early-Onset Muscle Disorders to Consider in the Differential Diagnosis of Salih Myopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK83297/table/salih-myo.T.earlyonset_muscle_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__salih-myo.T.earlyonset_muscle_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features</th></tr><tr><th headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4" id="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Salih myopathy</th><th headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4" id="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Salih myopathy</th></tr></thead><tbody><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sma/">Spinal muscular atrophy</a> (SMA)</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMN1</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Early-onset muscle weakness (age 6-12 mos) (SMA II)</div></li><li class="half_rhythm"><div>Weakness &#x02192; frequent falling &#x00026; difficulty walking up &#x00026; down stairs (SMA III)</div></li><li class="half_rhythm"><div>Normal intelligence</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset age: &#x0003e;12 mos (SMA III)</div></li><li class="half_rhythm"><div>Frequent finger trembling</div></li><li class="half_rhythm"><div>Sparing of facial muscles</div></li><li class="half_rhythm"><div>Serum CK: normal</div></li><li class="half_rhythm"><div>ECG: frequent background tremors but no cardiac involvement</div></li><li class="half_rhythm"><div>EMG: neurogenic features (polyphasic waves, positive sharp waves &#x00026; fibrillations) (versus myopathic EMG features seen in Salih myopathy)</div></li><li class="half_rhythm"><div>Skeletal muscle histology: group atrophy of type 1 &#x00026; type 2 muscle fibers (vs type 1 fiber predominance seen in Salih myopathy)</div></li></ul>
</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dbmd/">Duchenne muscular dystrophy</a></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DMD</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Usually manifests in early childhood w/delayed milestones</div></li><li class="half_rhythm"><div>Subclinical or clinical cardiac involvement presents in majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Serum CK: &#x02191; (&#x0003e;10-300x normal)</div></li><li class="half_rhythm"><div>ECG: characteristic pattern</div></li><li class="half_rhythm"><div>Skeletal muscle histology: established dystrophic morphology early in childhood</div></li><li class="half_rhythm"><div>Immunohistochemical staining of skeletal muscle: negative for dystrophin</div></li></ul>
</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sarcoglycanopathies&#x000a0;<sup>1</sup></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SGCA</i><br /><i>SGCB</i><br /><i>SGCG</i><br /><i>SGCD</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset age: 3-15 yrs</div></li><li class="half_rhythm"><div>In some, delayed walking &#x00026; frequent falling</div></li><li class="half_rhythm"><div>Cardiomyopathy</div></li><li class="half_rhythm"><div>ECG: left anterior fascicular block</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Serum CK: &#x02191; (10-70x normal)</div></li><li class="half_rhythm"><div>ECG: tall R wave in V1 &#x00026; V2 (vs Salih myopathy, in which deep S waves are seen in the right precordial leads associated w/&#x02193; R/S ratio; see <a class="figpopup" href="/books/NBK83297/figure/salih-myo.F1/?report=objectonly" target="object" rid-figpopup="figsalihmyoF1" rid-ob="figobsalihmyoF1">Figure 1</a>)</div></li><li class="half_rhythm"><div>Echocardiogram: left ventricular dysfunction associated w/regional wall motion abnormalities (e.g., inferior wall &#x00026; posterior septum hypokinesia) (vs Salih myopathy, in which the contractile dysfunction &#x00026; dilatation, initially restricted to the left ventricle, subsequently affects all chambers)</div></li><li class="half_rhythm"><div>Skeletal muscle histology: dystrophic early in disease course</div></li><li class="half_rhythm"><div>Immunohistochemical staining of skeletal muscle: negative staining for &#x02265;1 of the sarcoglycans &#x003b1; (adhalin), &#x003b2;, &#x003b3;, &#x00026; &#x003b4;</div></li></ul>
</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscular dystrophy-dystroglycanopathy (limb-girdle), type C5 (previously LGMD2I; OMIM <a href="https://omim.org/entry/607155" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">607155</a>)</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FKRP</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset age: &#x0003c;1 yr</div></li><li class="half_rhythm"><div>In some, infantile cardiomyopathy</div></li><li class="half_rhythm"><div>Muscle weakness &#x00026; calf muscle hypertrophy</div></li><li class="half_rhythm"><div>Skeletal muscle histology: in some, mild myopathic features (but significantly &#x02193; signal w/&#x003b1;-dystroglycan on immunostaining)</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Absence of ptosis</div></li><li class="half_rhythm"><div>Serum CK: elevated</div></li><li class="half_rhythm"><div>ECG: <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> notched P-waves, complete or incomplete right BBB or incomplete left BBB, &#x00026; Q waves in lateral leads</div></li></ul>
</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LGMD2J</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTN</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#salih-myo.Genetically_Related_Allelic_Di">Genetically Related Disorders</a>.</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#salih-myo.Genetically_Related_Allelic_Di">Genetically Related Disorders</a>.</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fcmd/">Fukuyama CMD</a></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FKRP</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Muscle weakness typically begins at birth or in early infancy.</div></li><li class="half_rhythm"><div>Children present w/delay or arrest of gross motor development.</div></li><li class="half_rhythm"><div>Dilated cardiomyopathy</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Variable eye malformations</div></li><li class="half_rhythm"><div>Brain MRI: central nervous system malformations</div></li></ul>
</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mdef-cmd/"><i>LAMA2</i>-related muscular dystrophy</a></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LAMA2</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital hypotonia</div></li><li class="half_rhythm"><div>Delayed or arrested motor milestones</div></li><li class="half_rhythm"><div>Progressive diffuse joint contractures</div></li><li class="half_rhythm"><div>Spinal rigidity</div></li><li class="half_rhythm"><div>Normal cognitive abilities in majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>~1/3 of individuals develop left ventricular dysfunction</div></li><li class="half_rhythm"><div>Myopathic facies</div></li><li class="half_rhythm"><div>&#x000b1; calf muscle hypertrophy</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Brain MRI: diffuse white matter signal abnormalities</div></li><li class="half_rhythm"><div>Immunohistochemical staining of skeletal muscle: total or partial merosin deficiency</div></li></ul>
</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNA</i>-related CMD (OMIM <a href="https://omim.org/entry/613205" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613205</a>)</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNA</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Infantile hypotonia &#x00026; weakness of axial-cervical muscles</div></li><li class="half_rhythm"><div>Dilated cardiomyopathy</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial weakness</div></li><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Muscle pseudohypertrophy</div></li></ul>
</td></tr><tr><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Classic multiminicore disease (OMIM <a href="https://omim.org/entry/606210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606210</a>, <a href="https://omim.org/entry/180901" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">180901</a>)</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RYR1</i><br /><i>SELENON</i></td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />(AD)</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal hypotonia &#x00026; early-onset delayed motor development</div></li><li class="half_rhythm"><div>Weakness of trunk &#x00026; neck flexors &#x0003e; pelvic &#x00026; shoulder girdle muscles</div></li><li class="half_rhythm"><div>Individuals usually ambulatory</div></li><li class="half_rhythm"><div>Facial muscle weakness ranging from absent to severe</div></li><li class="half_rhythm"><div>Serum CK: may be slightly &#x02191;.</div></li><li class="half_rhythm"><div>Similar skeletal muscle histology</div></li></ul>
</td><td headers="hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_1_4 hd_h_salih-myo.T.earlyonset_muscle_disorders_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Major respiratory involvement requiring respiratory support</div></li><li class="half_rhythm"><div>Cardiac involvement (right ventricular failure, cardiomyopathy) secondary to respiratory impairment</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; BBB = bundle branch block; CMD = <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy; EMG = electromyography; LGMD = limb-girdle muscular dystrophy; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = X linked</p></div></dd><dt>1. </dt><dd><div id="salih-myo.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#salih-myo.REF.nigro.2014.1">Nigro &#x00026; Savarese [2014]</a></p></div></dd></dl></div></div></div></div><div id="salih-myo.Management"><h2 id="_salih-myo_Management_">Management</h2><div id="salih-myo.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Salih myopathy, the evaluations summarized in <a class="figpopup" href="/books/NBK83297/table/salih-myo.T.recommended_evaluations_foll/?report=objectonly" target="object" rid-figpopup="figsalihmyoTrecommendedevaluationsfoll" rid-ob="figobsalihmyoTrecommendedevaluationsfoll">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="salih-myo.T.recommended_evaluations_foll" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis of Salih Myopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK83297/table/salih-myo.T.recommended_evaluations_foll/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__salih-myo.T.recommended_evaluations_foll_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>CNS</b></td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic examination</td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In individuals age &#x02265;5 yrs:
<ul><li class="half_rhythm"><div>Referral to a cardiologist</div></li><li class="half_rhythm"><div>ECG</div></li><li class="half_rhythm"><div>24-hr Holter ECG</div></li><li class="half_rhythm"><div>Echocardiogram</div></li></ul>
</td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for cardiomyopathy &#x00026;/or arrhythmia.</td></tr><tr><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pulmonary</b></td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Respiratory rate assessment</div></li><li class="half_rhythm"><div>Pulmonary function testing</div></li></ul>
</td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for restrictive lung disease.</td></tr><tr><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation w/physical &#x00026; occupational therapists</td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess strength &#x00026; joint mobility.</td></tr><tr><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Spinal x-rays for individuals age &#x02265;10 yrs</td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for presence of scoliosis.</td></tr><tr><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_salih-myo.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ECG = electrocardiogram</p></div></dd></dl></div></div></div></div><div id="salih-myo.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment involves prompt management of disease manifestations using a multidisciplinary approach that includes specialists in pediatric neurology, physiotherapy, occupational therapy, orthopedics, cardiology, and pulmonology.</p><p>Stretching exercises and physical therapy help prevent contractures and promote mobility. Assistive mechanical devices including orthotics, canes, and walkers can be used as needed.</p><p>Individuals with Salih myopathy have normal cognition: technical support should be provided in the school environment. Stimulation and emotional support can improve school performance and sense of social involvement.</p><p>Parents and/or caregivers should be made aware of the symptoms of heart failure, arrhythmia (including presyncope and syncope), and thromboembolic disease, and of the need to urgently seek medical care when any of these symptoms appear.</p><p>Training of caregivers in cardiopulmonary resuscitation may be suggested once the symptoms of cardiomyopathy start.</p><p>Adequate posture should be maintained when lying prone and sitting. Garchois brace (made of plexidur, a rigid but light and heat-deformable material) is used to reduce the degree of deformity and slow the progression of scoliosis [<a class="bk_pop" href="#salih-myo.REF.wang.2010.1559">Wang et al 2010</a>].</p><p>Cardiac transplantation should be considered for progressive dilated cardiomyopathy and heart failure refractory to medical therapy.</p></div><div id="salih-myo.Prevention_of_Secondary_Compli"><h3>Prevention of Secondary Complications</h3><p>Annual influenza vaccine and other respiratory infection-related immunizations are advised.</p><p>Lower respiratory tract infections should be treated aggressively when they occur.</p></div><div id="salih-myo.Surveillance"><h3>Surveillance</h3><div id="salih-myo.T.recommended_surveillance_for" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Salih Myopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK83297/table/salih-myo.T.recommended_surveillance_for/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__salih-myo.T.recommended_surveillance_for_lrgtbl__"><table><thead><tr><th id="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>ECG</div></li><li class="half_rhythm"><div>24-hr Holter ECG</div></li><li class="half_rhythm"><div>Echocardiogram</div></li></ul>
</td><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Every 6 mos starting at age 5 yrs</td></tr><tr><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pulmonary</b></td><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Respiratory function, using pulmonary function testing or spirometry</td><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually starting at age 10 yrs</td></tr><tr><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical examination &#x00026; x-rays as needed for orthopedic complications (e.g., foot deformity, joint contractures, spinal deformity)</td><td headers="hd_h_salih-myo.T.recommended_surveillance_for_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As needed</td></tr></tbody></table></div></div></div><div id="salih-myo.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Ibuprofen (Brufen<sup>&#x000ae;</sup>):</p><ul><li class="half_rhythm"><div>Give with care in those with evidence of cardiomyopathy. A patient who had reduced left ventricular ejection fraction developed edema following its administration [Subahi &#x00026; Salih, unpublished observation].</div></li><li class="half_rhythm"><div>Avoid in those with congestive heart failure.</div></li></ul></div><div id="salih-myo.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>Early diagnosis of at-risk sibs by clinical examination and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is important in order to monitor motor development and cardiac function so that treatment can be instituted promptly.</p><p>See <a href="#salih-myo.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="salih-myo.Pregnancy_Management"><h3>Pregnancy Management</h3><p>If a fetus is diagnosed prenatally with Salih myopathy, special considerations are needed at and following delivery since muscle weakness may manifest during the neonatal period.</p></div><div id="salih-myo.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="salih-myo.Genetic_Counseling"><h2 id="_salih-myo_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="salih-myo.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Salih myopathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="salih-myo.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers) of one Salih myopathy-related <i>TTN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic. Note: In contrast to individuals with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>TTN</i> associated with Udd distal myopathy, the parents of individuals with Salih myopathy remain asymptomatic with no cardiac or muscle disorder (<a class="figpopup" href="/books/NBK83297/figure/salih-myo.F4/?report=objectonly" target="object" rid-figpopup="figsalihmyoF4" rid-ob="figobsalihmyoF4">Figure 4</a>).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with Salih myopathy are not known to have reproduced.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>TTN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="salih-myo.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members requires prior identification of the <i>TTN</i> pathogenic variants in the family.</p></div><div id="salih-myo.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#salih-myo.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="salih-myo.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>TTN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for Salih myopathy are possible.</p></div></div><div id="salih-myo.Resources"><h2 id="_salih-myo_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Muscular Dystrophy Association - Canada</b></div><div>2345 Yonge Street</div><div>Suite 900</div><div>Toronto Ontario M4P 2E5</div><div>Canada</div><div><b>Phone:</b> 866-687-2538 (toll-free); 416-488-0030</div><div><b>Fax:</b> 416-488-7523</div><div><b>Email:</b> info@muscle.ca</div><div><a href="http://www.muscle.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.muscle.ca</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>Congenital Muscle Disease International Registry (CMDIR)</b></div><div><i>The CMDIR is a patient self-report registry with the goal to register the global <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscle disease population including persons with congenital myopathy, congenital muscular dystrophy, and congenital myasthenic syndrome. The CMDIR registers <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of all ages with symptoms from birth through late onset (limb-girdle). Registrants will receive educational information and connections to others in the CMD community, and will be contacted about potential participation in clinical trials for their CMD subtype.</i></div><div>19401 South Vermont Avenue</div><div>Suite J100</div><div>Torrance CA 90502</div><div><b>Phone:</b> 323-250-2399</div><div><b>Fax:</b> 310-684-2023</div><div><b>Email:</b> counselor@cmdir.org; sarah.foye@cmdir.org</div><div><a href="http://www.cmdir.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cmdir.org</a></div></li></ul></div><div id="salih-myo.Molecular_Genetics"><h2 id="_salih-myo_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="salih-myo.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Salih Myopathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK83297/table/salih-myo.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__salih-myo.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_salih-myo.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_salih-myo.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_salih-myo.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_salih-myo.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_salih-myo.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_salih-myo.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_salih-myo.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7273" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TTN</i></a></td><td headers="hd_b_salih-myo.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7273" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q31<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_salih-myo.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8WZ42" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Titin</a></td><td headers="hd_b_salih-myo.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/TTN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TTN homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_salih-myo.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TTN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TTN</a></td><td headers="hd_b_salih-myo.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TTN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TTN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="salih-myo.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="salih-myo.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Salih Myopathy (<a href="/omim/188840,611705" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK83297/table/salih-myo.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__salih-myo.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/188840" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">188840</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TITIN; TTN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611705" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611705</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SALIH MYOPATHY; SALMY</td></tr></tbody></table></div></div><div id="salih-myo.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>To date, <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants reported to cause Salih myopathy are small frameshift deletions in <i>TTN</i> exons Mex1 and Mex3 in <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families of Moroccan and Sudanese origin [<a class="bk_pop" href="#salih-myo.REF.carmignac.2007.340">Carmignac et al 2007</a>]. Carriers of these frameshift variants (i.e., heterozygotes) are asymptomatic, presumably as a result of <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay (NMD) of the mutated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a>. Since homozygotes survive, the NMD cannot be complete. Some titin protein that lacks the last C-terminal domains is produced. Whether the total decrease of titin protein or the loss of C terminus is more important for the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is not known.</p><p><b>Gene structure.</b> The longest <i>TTN</i> transcript, NM_001267550.1, has 363 exons with a coding capacity of 113,414 bp. <i>TTN</i> has a large number of alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants, which can result in confusion in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and nucleotide numbering in the literature [<a class="bk_pop" href="#salih-myo.REF.bang.2001.1065">Bang et al 2001</a>, <a class="bk_pop" href="#salih-myo.REF.guo.2010.753675">Guo et al 2010</a>, <a class="bk_pop" href="#salih-myo.REF.savarese.2018b.557">Savarese et al 2018b</a>]. Transcript variant (N2A) <a href="/nuccore/NM_133378.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_133378.4</a> is a long transcript with 312 exons that encodes the isoform N2A, the predominant titin isoform in skeletal muscle. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK83297/#salih-myo.molgen.TA">Table A</a>, <b>Gene</b>.</p><p>The Mex1 &#x02013; Mex6 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> exons correspond to the following exons:</p><ul><li class="half_rhythm"><div>LRG_391 (NG_011618.3): exons 359-364</div></li><li class="half_rhythm"><div>NM_133378.4: exons 307-312</div></li><li class="half_rhythm"><div>NM_001267550.1: exons 358-363</div></li><li class="half_rhythm"><div>NM_001256850.1: exons 307-312</div></li></ul><p><b>Pathogenic variants.</b> To date, the <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants reported to cause Salih myopathy are small frameshift deletions in <i>TTN</i> exons Mex1 and Mex3 in two <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families of Moroccan and Sudanese origin [<a class="bk_pop" href="#salih-myo.REF.carmignac.2007.340">Carmignac et al 2007</a>] (<a class="figpopup" href="/books/NBK83297/table/salih-myo.T.earlyonset_muscle_disorders/?report=objectonly" target="object" rid-figpopup="figsalihmyoTearlyonsetmuscledisorders" rid-ob="figobsalihmyoTearlyonsetmuscledisorders">Table 2</a>).</p><div id="salih-myo.T.selected_ttn_pathogenic_vari" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Selected <i>TTN</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK83297/table/salih-myo.T.selected_ttn_pathogenic_vari/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__salih-myo.T.selected_ttn_pathogenic_vari_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th></tr></thead><tbody><tr><td headers="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.105528_105535del<br />(c.97824_97831del)&#x000a0;<sup>2</sup><br />(g.289385_289392delACCAAGTG)&#x000a0;<sup>3</sup></td><td headers="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln35176HisfsTer9<br />(p.Gln32608HisfsTer9)&#x000a0;<sup>2</sup><br />(Q33535HRfsTer7)&#x000a0;<sup>3</sup></td><td headers="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001267550.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001267550<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_001254479.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001254479<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.106571delA<br />(c.98867delA)&#x000a0;<sup>2</sup><br />(g.289390_289397delA or 291297delA)&#x000a0;<sup>3</sup></td><td headers="hd_h_salih-myo.T.selected_ttn_pathogenic_vari_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys35524ArgfsTer22<br />(p.Lys32956ArgfsTer22)&#x000a0;<sup>2</sup><br />(Lys33883ArgfsTer20)&#x000a0;<sup>3</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="salih-myo.TF.5.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="salih-myo.TF.5.2"><p class="no_margin">Reference sequence: <a href="/nuccore/NM_133378.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_133378<wbr style="display:inline-block"></wbr>​.4</a> (<a href="/protein/NP_596869.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_596869<wbr style="display:inline-block"></wbr>​.4</a>)</p></div></dd><dt>3. </dt><dd><div id="salih-myo.TF.5.3"><p class="no_margin">Reference sequence: <a href="/nuccore/AJ277892.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AJ277892<wbr style="display:inline-block"></wbr>​.2</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Titin is the biggest single polypeptide in humans, found in numerous <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of varying size. The entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> predicts a protein of 38,138 amino acids (4,200 kd). Titin is expressed as several different isoforms, caused by alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, in different skeletal muscles and in cardiac muscle [<a class="bk_pop" href="#salih-myo.REF.bang.2001.1065">Bang et al 2001</a>, <a class="bk_pop" href="#salih-myo.REF.guo.2010.753675">Guo et al 2010</a>].</p><p>Titin functions as a template in sarcomere assembly and for maintenance of sarcomere integrity. The titin protein is the third myofilament in the sarcomere along with myosin and actin filaments. Titin spans more than one half the length of a sarcomere in heart and skeletal muscle. Structurally different parts of the protein perform distinct functions (mechanical, developmental, and regulatory) [<a class="bk_pop" href="#salih-myo.REF.carmignac.2007.340">Carmignac et al 2007</a>]. Titin binds and interacts with a large number of other sarcomeric proteins.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The predicted truncated titin proteins resulting from the frameshift variants in Mex1, Mex2, and Mex3 are incorporated into ultrastructurally normal sarcomeres in <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#salih-myo.REF.carmignac.2007.340">Carmignac et al 2007</a>]. Therefore, absence of the last five (Mex2-Mex6) exons is compatible with life but causes this severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorder. Asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> carriers of these titin deletions presumably have sufficient full-length titin to result in normal sarcomere function.</p></div></div><div id="salih-myo.References"><h2 id="_salih-myo_References_">References</h2><div id="salih-myo.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.bang.2001.1065">Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. <span><span class="ref-journal">Circ Res. </span>2001;<span class="ref-vol">89</span>:1065–72.</span> [<a href="/pubmed/11717165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11717165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.carmignac.2007.340">Carmignac V, Salih MAM, Quijano-Roy S, Marchand S, Marchand S, Al Rayess MM, Mukhtar MM, Ja U, Labeit S, Guicheney P, Leturcq F, Gautel M, Fardau M, Campbell KP, Richard I, Estournet B, Ferreiro A. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. <span><span class="ref-journal">Ann Neurol. </span>2007;<span class="ref-vol">61</span>:340–51.</span> [<a href="/pubmed/17444505" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17444505</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.fukuzawa.2008.1841">Fukuzawa A, Lange S, Holt M, Vichola A, Carmignac V, Ferreiro A, Udd B, Gautel M. Interchains with titin and myomesin target obscuring and obscuring-like 1 to the M-band-implication for hereditary myopathies. <span><span class="ref-journal">J Cell Sci. </span>2008;<span class="ref-vol">121</span>:1841–51.</span> [<a href="/pubmed/18477606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18477606</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.guo.2010.753675">Guo W, Bharmal SJ, Esbona K, Greaser ML. Titin diversity--alternative splicing gone wild. <span><span class="ref-journal">J Biomed Biotechnol. </span>2010;<span class="ref-vol">2010</span>:753675.</span> [<a href="/pmc/articles/PMC2843904/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2843904</span></a>] [<a href="/pubmed/20339475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20339475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.hackman.2017.396">Hackman P, Udd B, B&#x000f6;nnemann CG, Ferreiro A, et al.  219th ENMC International Workshop Titinopathies International database of titin mutations and phenotypes, Heemskerk, The Netherlands, 29 April-1 May 2016. <span><span class="ref-journal">Neuromuscul Disord. </span>2017;<span class="ref-vol">27</span>:396–407.</span> [<a href="/pubmed/28214268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28214268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.nigro.2014.1">Nigro V, Savarese M. Genetic basis of limb-girdle muscular dystrophies: the 2014 update. <span><span class="ref-journal">Acta Myol. </span>2014;<span class="ref-vol">33</span>:1–12.</span> [<a href="/pmc/articles/PMC4021627/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4021627</span></a>] [<a href="/pubmed/24843229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24843229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.pernigo.2010.2908">Pernigo S, Fukuzawa A, Bertz M, Holt M, Reif M, Steiner RA, Gautel M. Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2010;<span class="ref-vol">107</span>:2908–13.</span> [<a href="/pmc/articles/PMC2814874/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2814874</span></a>] [<a href="/pubmed/20133654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20133654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.salih.1998.289">Salih MA, Al Rayess M, Cutshall S, Urtizberca JA, Al-Turaiki MH, Ozo CO, Straub V, Akbar M, Abid M, Andeejani A, Campell KP. A novel form of familial congenital muscular dystrophy in two adolescents. <span><span class="ref-journal">Neuropediatrics. </span>1998;<span class="ref-vol">29</span>:289–93.</span> [<a href="/pubmed/10029346" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10029346</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.savarese.2018a.11">Savarese M, Jonson PH, Huovinen S, Paulin L, Auvinen P, Udd B, Hackman P. The complexity of titin splicing pattern in human adult skeletal muscles. <span><span class="ref-journal">Skelet Muscle. </span>2018a;<span class="ref-vol">8</span>:11.</span> [<a href="/pmc/articles/PMC5874998/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5874998</span></a>] [<a href="/pubmed/29598826" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29598826</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.savarese.2018b.557">Savarese M, Maggi L, Vihola A, Jonson PH, Tasca G, Ruggiero L, Bello L, Magri F, Giugliano T, Torella A, Evil&#x000e4; A, Di Fruscio G, Vanakker O, Gibertini S, Vercelli L, Ruggieri A, Antozzi C, Luque H, Janssens S, Pasanisi MB, Fiorillo C, Raimondi M, Ergoli M, Politano L, Bruno C, Rubegni A, Pane M, Santorelli FM, Minetti C, Angelini C, De Bleecker J, Moggio M, Mongini T, Comi GP, Santoro L, Mercuri E, Pegoraro E, Mora M, Hackman P, Udd B, Nigro V. Interpreting genetic variants in titin in patients with muscle disorders. <span><span class="ref-journal">JAMA Neurol. </span>2018b;<span class="ref-vol">75</span>:557–65.</span> [<a href="/pmc/articles/PMC5885217/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5885217</span></a>] [<a href="/pubmed/29435569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29435569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.savarese.2016.293">Savarese M, Sarparanta J, Vihola A, Udd B, Hackman P. Increasing role of titin mutations in neuromuscular disorders. <span><span class="ref-journal">J Neuromuscul Dis. </span>2016;<span class="ref-vol">3</span>:293–308.</span> [<a href="/pmc/articles/PMC5123623/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5123623</span></a>] [<a href="/pubmed/27854229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27854229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.subahi.2001.297">Subahi SA. Distinguishing cardiac features of a novel form of congenital muscular dystrophy (Salih cmd). <span><span class="ref-journal">Pediatr Cardiol. </span>2001;<span class="ref-vol">22</span>:297–301.</span> [<a href="/pubmed/11455396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11455396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="salih-myo.REF.wang.2010.1559">Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, Florence JM, Schara U, Schuler PM, Wahbi K, Aloysius A, Bash RO, B&#x000e9;roud C, Bertini E, Bushby K, Cohn RD, Connolly AM, Deconinck N, Desguerre I, Eagle M, Estournet-Mathiaud B, Ferreiro A, Fujak A, Goemans N, Iannaccone ST, Jouinot P, Main M, Melacini P, Mueller-Felber W, Muntoni F, Nelson LL, Rahbek J, Quijano-Roy S, Sewry C, Storhaug K, Simonds A, Tseng B, Vajsar J, Vianello A, Zeller R. Consensus statement on standard of care for congenital muscular dystrophies. <span><span class="ref-journal">J Child Neurol. </span>2010;<span class="ref-vol">25</span>:1559–81.</span> [<a href="/pmc/articles/PMC5207780/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5207780</span></a>] [<a href="/pubmed/21078917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21078917</span></a>]</div></li></ul></div></div><div id="salih-myo.Chapter_Notes"><h2 id="_salih-myo_Chapter_Notes_">Chapter Notes</h2><div id="salih-myo.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to thank Loida M Sese for secretarial work, and Sayed Taha and Vir Salvador for medical illustration.</p></div><div id="salih-myo.Author_History"><h3>Author History</h3><p>Virginie Carmignac, PhD (2012-present)<br />Peter Hackman, PhD (2012-present)<br />Mustafa Salih, MB BS, MPCH, MD, Dr Med Sci, FRCPCH, FAAN (2012-present)<br />Marco Savarese, PhD (2019-present)<br />Tiina Suominen, MSc; University of Helsinki (2012-2019)<br />Bjarne Udd, MD, PhD (2012-present)</p></div><div id="salih-myo.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 April 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 January 2012 (me) Review posted live</div></li><li class="half_rhythm"><div>28 October 2011 (mas) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK83297</span><span class="label">PMID: <a href="/pubmed/22238790" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">22238790</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/scs/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/siod/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK83297&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK83297/?report=reader">PubReader</a></li><li><a href="/books/NBK83297/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK83297" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK83297" style="display:none" title="Cite this Page"><div class="bk_tt">Hackman P, Savarese M, Carmignac V, et al. Salih Myopathy. 2012 Jan 12 [Updated 2019 Apr 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK83297/pdf/Bookshelf_NBK83297.pdf">PDF version of this page</a> (860K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#salih-myo.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#salih-myo.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#salih-myo.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#salih-myo.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#salih-myo.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#salih-myo.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#salih-myo.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#salih-myo.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#salih-myo.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#salih-myo.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#salih-myo.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7273[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TTN</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK83297+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2751642" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2751642" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2751642" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2751642" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301565" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Central Core Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malicdan MCV, Nishino I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301609" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Emery-Dreifuss Muscular Dystrophy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bonne G, Leturcq F, Ben Yaou R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301298" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Darras BT, Urion DK, Ghosh PS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23285490" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type IV</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type IV<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Magoulas PL, El-Hattab AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=22238790" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=22238790" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04180b39a66ee2ba38f2a2">Salih Myopathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Salih Myopathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:16:43-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D2D72E040E7210000000004230196&amp;ncbi_session=CE8D2D72E04180A1_1059SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK83297%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK83297&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK83297/&amp;ncbi_pagename=Salih Myopathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D2D72E04180A1_1059SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>